Braemar Hotels & Resorts (BHR) Q4 2025 earnings review
Strategic Sale Process Takes Center Stage Amidst Mixed Operational Results
Braemar's Q4 results were overshadowed by a massive $54.5 million impairment charge that drove a net loss of $(46.0) million. Operationally, the portfolio saw a deceleration, with Comparable RevPAR flat (+0.02%) as a 5.2% drop in occupancy fully offset a 5.4% gain in ADR. However, the true focal point for investors is the ongoing strategic sale process. The Board has effectively put the company in a holding pattern by suspending the 2026 common dividend policy and adjusting preferred dividend schedules to maintain flexibility for potential liquidations or piecemeal asset sales.
🐂 Bull Case
The luxury resort segment remains the primary growth engine, delivering a solid 4.1% comparable RevPAR growth and 6.0% comparable EBITDA growth in Q4, proving the underlying strength of the company's core assets.
The company successfully sold the 410-room The Clancy in San Francisco for $115 million (a healthy 5.2% cap rate) and redeemed $17.7 million of non-traded preferred stock in the quarter, actively fortifying the balance sheet.
🐻 Bear Case
Occupancy dropped 5.2% year-over-year to 60.8% in Q4. While management successfully pushed ADR up 5.4%, the sharp volume decline suggests luxury travelers are exhibiting price fatigue.
A non-cash impairment charge of $54.5 million severely damaged bottom-line profitability, highlighting potential structural valuation issues within certain non-core or underperforming assets.
⚖️ Verdict: ⚪
Neutral. The stock is currently trading as a special situation due to the active sale process. The underlying operational metrics show deceleration (flat RevPAR, falling occupancy), but aggressive asset sales and value-unlock initiatives limit the downside.
Key Themes
Capital Allocation Frozen Pending Company Sale
The ongoing strategic review, initiated in August 2025, has fundamentally altered Braemar's capital allocation. Management announced they have not declared a common dividend policy for 2026, citing the potential that assets may be sold in multiple transactions with proceeds distributed to shareholders. Additionally, preferred dividend declarations were moved to a monthly 'reserving' process to ensure parity and flexibility in the event of mid-quarter strategic transactions.
Occupancy Declines Neutralize Pricing Power
A Decelerating trend is evident in top-line volume. Comparable Occupancy fell 5.2% year-over-year in Q4 to 60.8%. While Braemar managed to drive a 5.4% increase in Average Daily Rate (ADR) to $559, the volume loss entirely offset the pricing gains, resulting in flat RevPAR. This indicates that the company may have reached a ceiling on its ability to push room rates without sacrificing significant occupancy.
Renovations Masking Core Stability
Reported portfolio results are being dragged down by significant ongoing renovations at three properties: Cameo Beverly Hills (repositioning to Hilton LXR), Hotel Yountville, and Park Hyatt Beaver Creek. When excluding these disrupted assets, Comparable RevPAR grew a healthier 2.6% and Comparable Hotel EBITDA increased 6.4%, showing that the stabilized properties are still expanding.
Floating Rate Debt Exposure
Braemar ended the year with $1.1 billion in total loans at a blended average interest rate of 6.7%. Notably, 86% of this debt is effectively floating. In a volatile interest rate environment, this lack of fixed-rate security places significant pressure on the company's cash flows as they navigate the sale process.
Other KPIs
Decelerating. Down from $30.2 million in 24Q4. The drop is largely a reflection of operational disruptions from three major hotel renovations and softness in urban market occupancies, despite the resort portfolio's 6.0% EBITDA growth.
A sudden shock to the income statement. While management did not specify the exact asset in the earnings release, this non-cash charge drove the massive $(46.0) million net loss for the quarter and suggests a severe downward reappraisal of specific real estate values on the balance sheet.
Accelerating. Up from $0.21 in FY24. Despite the widening net losses, AFFO improved year-over-year due to the add-backs of the large non-cash impairment charge and adjustments for real estate dispositions (like the Seattle and San Francisco sales).
Guidance
Reversing. The Board actively chose not to declare a 2026 dividend policy due to the ongoing strategic alternatives process. This represents a full halt on long-term capital return guidance to retain cash until the sale process concludes.
Key Questions
Impairment Details
You booked a massive $54.5 million impairment charge this quarter. Which specific assets triggered this write-down, and what does this imply about the carrying value of your remaining urban properties as you look to sell the company?
Pricing vs. Volume Trade-off
With occupancy down 5.2% but ADR up 5.4%, we are seeing a direct trade-off that resulted in flat RevPAR. Have you reached the limit of the luxury consumer's price elasticity, and will you need to sacrifice rate to regain occupancy in 2026?
Sale Process Timeline
The suspension of the 2026 dividend and the adjustment of preferred dividend scheduling signal that you are preparing for a near-term transaction. Can you provide any parameters on the expected timeline for concluding the strategic review?